2022 BioInfect Conference

2022 BioInfect Conference

Alderley Park Conference Centre
Wednesday 9th March 2022

About

The global COVID-19 pandemic has highlighted the importance of infectious disease control and antimicrobial resistance is one of the biggest public health challenges of our time. With the WHO declaring AMR one of the top 10 global public health threats facing humanity and with 3.57 million deaths associated with resistant pathogens in 2019, it is imperative that we tackle this serious threat now.
We can’t do it alone: a collaborative approach is needed across all sectors. BioInfect will look at the critical issues relating to the challenges of new anti-infective development,  the endemic problem of resistance, and the considerations for creating a truly global and effective response to antimicrobial resistance.


Antimicrobial resistance today
Antimicrobial resistance arises when the organisms that cause infection evolve ways to survive treatment. Once standard treatments are ineffective, it is easier for infections to persist and spread. These resistant organisms can be found in people, animals, food and the environment. The rise and spread of antimicrobial resistance are creating a new generation of ‘superbugs’ that cannot be treated with existing medicines. 

Drug-resistant bacteria infect over 50m people worldwide killing over 700,000 people each year. Without effective antibiotics, even minor surgery and routine operations could become high-risk procedures if serious infections can’t be treated.

2022 Attendees

In 2022 we are welcoming delegates from Alderley Park, Bruntwood SciTech, INFEX Therapeutics Ltd, Evotec, SRG, ProLab Diagnostics, Biocair, Liverpool School of Tropical Medicine, Blueberry Therapeutics Ltd, Lancaster University, Bugworks, Keele University, Cresset, Medicines Discovery Catapult, Quay Pharma, Biocair, F2G Ltd, National Physical Laboratory, University of Manchester, University of Leeds,  Aviva Investors, National Institute for Health and Clinical Excellence, BMG LABTECH Ltd, Perfectus Biomed, University of Sheffield, ProLab Diagnostics, ArrePath, Centauri Therapeutics, University of Liverpool, SEDA Pharmaceutical Development Services, MAST Group, Katalyzt Ltd., Illumina, Collaborative Drug Discovery CDD Vault, LightOx, PhenUtest Diagnostics, DSTL, WHP Engineering Ltd., 30 Technology, Phoenix Dx Ltd., Bouygues E&S, Source Bioscience, Safeguard Biosystems Holding, Appleyard Lees, Opillotech Ltd. and many more to follow.......

Agenda

08.30 – 08.55 Coffee and Registration

08.55 – 09.00 Conference Welcome Pia Thommes, Evotec

09.00 – 09.30 Global Perspectives Anand Anandkumar, The challenges and opportunities afforded by LMIC’s

09.30 – 10.30 Panel session - State of the AMR Nation 

Chair: Pia Thommes, Evotec
Abigail Herron, Sustainable Finance Centre for Excellence, Aviva Investors
Derek Lindsay, Infex Therapeutics
Anand Anadkumar, Bugworks
Helen Bright, Medicines Discovery Catapult 

12.00 - 12.20 Global Perspectives Colm Leonard, The NHS procurement of antibiotics scheme

Patient Engagement 1
12.20 - 12.40 Professor Paul Cooke, Jessica Mitchell, Nichola Jones, University of Leeds

12.40 – 13.50 Lunch, Networking & Exhibition

Global Perspectives Keynote 14.10 – 14.40
Global Perspectives
John Rex, Chief Medical Officer, F2G Ltd. Operating Partner, Advent Life Sciences. Adjunct Professor of Medicine, McGovern Medical School

Diagnostics 14.40 - 15.40
Chair: Mark Reed
Helen Dent, BIVDA
Mark Reed, Pro-Lab Diagnostics Impact on the Diagnostic Industry during the pandemic
Charlotte Duncan, Pro-Lab Diagnostics Host Response Diagnostics – Sepsis
Neil Bentley OBE, Pro-Lab Diagnostics

The Vivo Mimetic Media platform for discovering and characterizing novel mode of action antibiotics
15.40 - 16.10 Keynote
Sebastien Coyne, Evotec Lyon 

New antibiotics & approaches to replenish the pipeline – part 2 16.10 - 16.50
Professor Jason Micklefield, University of Manchester
Max Ryadnov, NP

16.50 - 17.00 Coffee & Networking 

  • Coffee and Registration

  • Conference Welcome

    Pia Thommes, Evotec

  • Global Perspectives Keynote

  • State of the AMR Nation

    Chair: Pia Thommes, Evotec

    Abigail Herron, Sustainable Finance Centre for Excellence, Aviva Investors 

    Derek Lindsay, Infex Therapeutics 

    Anand Anadkumar, Bugworks 

    Helen Bright, Medicines Discovery Catapult  

     

  • Coffee, Networking & Exhibition

  • New antibiotics & approaches to replenish the pipeline

    Professor Jon Sayers, Professor of Functional Genomics, University of Sheffield 

    Derek Lindsay, Infex Therapeutics 

    Andrew Wilkinson, Infex Therapeutics  

  • Global Perspectives Keynote

    • Prof. Colm Leonard, Consultant Clinical Adviser, National Institute for Health and Clinical Excellence
  • Patient Engagement

    Professor Paul Cooke, Jessica Mitchell, Nichola Jones, University of Leeds 

  • Lunch, Networking & Exhibition

  • Patient Engagement

    Dr Beverley Isherwood, Partnership Lead, Medicines Discovery Catapult 

    Partnering for Impact: The CF AMR Syndicate 

  • Global Perspectives Keynote

    • John H. Rex, MD, Chief Medical Officer, F2G Ltd. · Operating Partner, Advent Life Sciences · Adjunct Professor of Medicine, McGovern Medical School
  • Diagnostics

    Helen Dent, BIVDA

    Mark Reed, Pro-Lab Diagnostics 

    Charlotte Duncan, Pro-Lab Diagnostics 

    Neil Bentley OBE, Pro-Lab Diagnostics

  • The Vivo Mimetic Media platform for discovering and characterizing novel mode of action antibiotics

    Sebastien Coyne, Evotec Lyon  

  • New antibiotics & approaches to replenish the pipeline

    Professor Jason Micklefield, University of Manchester  

    Max Ryadnov, NPL 

  • Coffee and Networking

Sponsors

Keynote Speakers

 

John H. Rex, MD

Chief Medical Officer, F2G Ltd. · Operating Partner, Advent Life Sciences · Adjunct Professor of Medicine, McGovern Medical School,

I am a physician and drug developer with more than 30 years...

Dr Anand Anandkumar

Co-Founder & Chief Executive Officer, Bugworks Research Inc

Dr. Anandkumar is a serial entrepreneur in biotechnology and...

Prof. Colm Leonard

Consultant Clinical Adviser, National Institute for Health and Clinical Excellence

Prof Colm Leonard is a Consultant Thoracic Physician at Manc...

Sébastien Coyne

PharmD PhD Group Leader, Anti-Infectives, Evotec

Sébastien Coyne studied pharmacy at the University of...

Registration

Registration will open shortly. For any further queries please contact info@bionow.co.uk

Gold Exhibitors

 

 

There are limited exhibitor opportunities available, further information can be found here.